Bibliography
Found 45 results
Filters: Author is Hinkin, Charles H [Clear All Filters]
Neurocognition and Medication Adherence in HIV-Infected Adults. In: Social Neuroscience and Health. 2013th ed. Social Neuroscience and Health. Springer Publications; 2013. pp. 85-108.
. Assessment of the NEUROPSI in Detecting Neurocognitive Deficits in HIV+ Spanish Speakers. In: 38th annual meeting of the International Neuropsychological Society. 38th annual meeting of the International Neuropsychological Society. Acapulco, Mexico; 2010.
. Cross-section effects of APOE E4 by Discrete Neurocognitive Domain. In: 40th Annual Conference of the International Neuropsychological Society. 40th Annual Conference of the International Neuropsychological Society. ; 2012.
. Cross-sectional and longitudinal studies of medication adherence and cognition among HIV+ adults. In: 38th annual meeting of the International Neuropsychological Society. 38th annual meeting of the International Neuropsychological Society. Acapulco, Mexico; 2010.
. Education stratification based on education versus reading ability: a comparison of diagnostic accuracy of neurocognitive impairment in HIV. In: Western Student Medical Research Forum (WSMRF). Western Student Medical Research Forum (WSMRF). Carmel, CA; 2006.
. Ethnicity and Risk for HIV-Associated Neurocognitive Disorders. In: HIV Research: The Next Generation Conference. HIV Research: The Next Generation Conference. Los Angeles, CA; 2007.
. Gray matter atrophy among older adults with HIV: The effects of age and disease status. In: 9th annual meeting of the American Academy of Clinical Neuropsychology. 9th annual meeting of the American Academy of Clinical Neuropsychology. Washington, DC; 2010.
. HIV and Aging: The interactive effects of aging and cocaine use on neurocognition. In: International Neuropsychological Society’s 39th Annual Meeting. International Neuropsychological Society’s 39th Annual Meeting. Boston, MA; 2011.
. The Interplay between APOE EF, Disease Severity, and Cognition. In: 92nd Annual Conference of the Western Psychological Association. 92nd Annual Conference of the Western Psychological Association. ; 2012.
. Longitudinal changes in medication adherence among HIV+ adults: Relationship with neurocognition and changes in psychiatric functioning. In: 29th annual meeting of the National Academy of Neuropsychology. 29th annual meeting of the National Academy of Neuropsychology. New Orleans, Louisiana; 2009.
. Longitudinal Changes in Medication Adherence among HIV-infected adults: A Hierarchical Linear Modeling Approach. In: 9th annual conference of the American Academy of Clinical Neuropsychology. 9th annual conference of the American Academy of Clinical Neuropsychology. ; 2011.
. Longitudinal effects of APOE e4 on HIV-Associated Neurocognitive Dysfunction. In: Annual Meeting of the International Neuropsychological Society. Annual Meeting of the International Neuropsychological Society. ; 2012.
. Long-term outcome of everyday functioning and neurocognitive ability following CNS opportunistic infection in AIDS. In: 132nd Annual Meeting of the American Neurological Assocation. 132nd Annual Meeting of the American Neurological Assocation. Washington, D.C.; 2007.
Neuropsychological effects of HIV and Hepatitis C co-infection. In: 34th Annual Meeting of the International Neuropsychological Society. 34th Annual Meeting of the International Neuropsychological Society. Boston, MA; 2006.
. Predictors of longitudinal medication adherence: Evidence from an integrative model. In: 9th annual meeting of the American Academy of Clinical Neuropsychology. 9th annual meeting of the American Academy of Clinical Neuropsychology. ; 2011.
. Psychiatric and Cognitive Concomitants of HIV and HCV Co-Infection. In: NIDA Symposium on Issues in the Medical Management of HIV/HCV Co-Infection in IDUs. NIDA Symposium on Issues in the Medical Management of HIV/HCV Co-Infection in IDUs. Washington, D.C.; 2004.
. Response inhibition impairment and stimulant abuse in HIV+ adults. In: Twenty-Ninth Annual Meeting of the International Neuropsychological Society. Vol. 7. Twenty-Ninth Annual Meeting of the International Neuropsychological Society. Chicago, IL; 2001. p. 151.
. . .
Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehavioral HIV Medicine [Internet]. 2013 ;Volume 2013:5:11-22. Available from: http://www.dovepress.com/apolipoprotein-e-genotype-and-human-immunodeficiency-virus-associated--peer-reviewed-article-NBHIV
CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehavioral HIV Medicine [Internet]. 2009 ;1:1-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20725607
. Cognitive reserve masks the neurobehavioral expression of HIV neurological disorder in older adults. Neurobehavioral HIV Medicine. 2011 ;3:87-93.
. A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers. Neurobehav HIV Med. 2011 ;3:79-86.
. Depression, cognition, and self-appraisal of functional ability in HIV: An examination of subjective appraisal versus objective performance. The Clinical Neuropsychologist [Internet]. 2011 ;25:224-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=%2021331979
. Education correction using years in school or reading grade-level equivalent? Comparing the accuracy of two methods in diagnosing HIV-associated neurocognitive impairment. Journal of the International Neuropsychological Society (JINS) [Internet]. 2007 ;13(3):462-470. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17445295
.